Spero Therapeutics Inc (SPRO) USD0.001

Sell:$2.91Buy:$2.92Price decreased$0.02 (0.68%)

NASDAQ:Price increased0.87%
Market closed |
Prices delayed by at least 15 minutes
Sell:$2.91
Buy:$2.92
Change:Price decreased$0.02 (0.68%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$2.91
Buy:$2.92
Change:Price decreased$0.02 (0.68%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
4 May 2026
Esther RajaveluCFO
Sell
Tax related
25,240$2.51$63,352.40986,851
6 February 2026
Esther RajaveluCFO
Sell
Tax related
37,101$2.36$87,558.361,062,907
6 February 2026
Esther RajaveluCFO
Sell
Tax related
50,816$2.36$119,925.761,012,091
6 February 2026
Timothy KeutzerCOO
Sell
Tax related
18,652$2.36$44,018.72742,506
4 February 2026
Timothy KeutzerCOO
Sell
Tax related
3,471$2.24$7,775.04761,158
3 February 2026
Timothy KeutzerCOO
Sell
Tax related
24,224$2.14$51,839.36764,629
2 February 2026
Esther RajaveluCFO
Sell
Tax related
18,442$2.20$40,572.401,100,008
2 February 2026
Timothy KeutzerCOO
Sell
Tax related
18,891$2.20$41,560.20788,853
7 November 2025
Esther RajaveluCFO
Sell
Tax related
40,270$2.37$95,439.90869,450
28 August 2025
Timothy KeutzerCOO
Sell
Tax related
1,695$1.97$3,339.15739,744

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
6 February 2026
Esther RajaveluCFO
Sell
Tax related
50,816$2.36$119,925.761,012,091
7 November 2025
Esther RajaveluCFO
Sell
Tax related
40,270$2.37$95,439.90869,450
6 February 2026
Esther RajaveluCFO
Sell
Tax related
37,101$2.36$87,558.361,062,907
4 May 2026
Esther RajaveluCFO
Sell
Tax related
25,240$2.51$63,352.40986,851
3 February 2026
Timothy KeutzerCOO
Sell
Tax related
24,224$2.14$51,839.36764,629

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.